Recent Approaches for Downplaying Antibiotic Resistance: Molecular Mechanisms. 2023

Sarfraz Ahmed, and Muhammad Zeeshan Ahmed, and Safa Rafique, and Seham Eid Almasoudi, and Mohibullah Shah, and Nur Asyilla Che Jalil, and Suvash Chandra Ojha
Department of Basic Sciences, University of Veterinary and Animal Sciences Lahore, Narowal Campus, 51600 Narowal, Pakistan.

Antimicrobial resistance (AMR) is a ubiquitous public health menace. AMR emergence causes complications in treating infections contributing to an upsurge in the mortality rate. The epidemic of AMR in sync with a high utilization rate of antimicrobial drugs signifies an alarming situation for the fleet recovery of both animals and humans. The emergence of resistant species calls for new treatments and therapeutics. Current records propose that health drug dependency, veterinary medicine, agricultural application, and vaccination reluctance are the primary etymology of AMR gene emergence and spread. Recently, several encouraging avenues have been presented to contest resistance, such as antivirulent therapy, passive immunization, antimicrobial peptides, vaccines, phage therapy, and botanical and liposomal nanoparticles. Most of these therapies are used as cutting-edge methodologies to downplay antibacterial drugs to subdue the resistance pressure, which is a featured motive of discussion in this review article. AMR can fade away through the potential use of current cutting-edge therapeutics, advancement in antimicrobial susceptibility testing, new diagnostic testing, prompt clinical response, and probing of new pharmacodynamic properties of antimicrobials. It also needs to promote future research on contemporary methods to maintain host homeostasis after infections caused by AMR. Referable to the microbial ability to break resistance, there is a great ultimatum for using not only appropriate and advanced antimicrobial drugs but also other neoteric diverse cutting-edge therapeutics.

UI MeSH Term Description Entries
D011634 Public Health Branch of medicine concerned with the prevention and control of disease and disability, and the promotion of physical and mental health of the population on the international, national, state, or municipal level. Community Health,Environment, Preventive Medicine & Public Health,Environment, Preventive Medicine and Public Health,Health, Community,Health, Public
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D014612 Vaccines Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases. Vaccine
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance

Related Publications

Sarfraz Ahmed, and Muhammad Zeeshan Ahmed, and Safa Rafique, and Seham Eid Almasoudi, and Mohibullah Shah, and Nur Asyilla Che Jalil, and Suvash Chandra Ojha
January 2015, Nature reviews. Microbiology,
Sarfraz Ahmed, and Muhammad Zeeshan Ahmed, and Safa Rafique, and Seham Eid Almasoudi, and Mohibullah Shah, and Nur Asyilla Che Jalil, and Suvash Chandra Ojha
April 2011, Chemical communications (Cambridge, England),
Sarfraz Ahmed, and Muhammad Zeeshan Ahmed, and Safa Rafique, and Seham Eid Almasoudi, and Mohibullah Shah, and Nur Asyilla Che Jalil, and Suvash Chandra Ojha
October 2017, Journal of medicinal chemistry,
Sarfraz Ahmed, and Muhammad Zeeshan Ahmed, and Safa Rafique, and Seham Eid Almasoudi, and Mohibullah Shah, and Nur Asyilla Che Jalil, and Suvash Chandra Ojha
May 2023, Nature reviews. Microbiology,
Sarfraz Ahmed, and Muhammad Zeeshan Ahmed, and Safa Rafique, and Seham Eid Almasoudi, and Mohibullah Shah, and Nur Asyilla Che Jalil, and Suvash Chandra Ojha
January 2024, Frontiers in microbiology,
Sarfraz Ahmed, and Muhammad Zeeshan Ahmed, and Safa Rafique, and Seham Eid Almasoudi, and Mohibullah Shah, and Nur Asyilla Che Jalil, and Suvash Chandra Ojha
November 2020, Biochemistry. Biokhimiia,
Sarfraz Ahmed, and Muhammad Zeeshan Ahmed, and Safa Rafique, and Seham Eid Almasoudi, and Mohibullah Shah, and Nur Asyilla Che Jalil, and Suvash Chandra Ojha
June 2011, Central nervous system agents in medicinal chemistry,
Sarfraz Ahmed, and Muhammad Zeeshan Ahmed, and Safa Rafique, and Seham Eid Almasoudi, and Mohibullah Shah, and Nur Asyilla Che Jalil, and Suvash Chandra Ojha
February 2024, Nature reviews. Microbiology,
Sarfraz Ahmed, and Muhammad Zeeshan Ahmed, and Safa Rafique, and Seham Eid Almasoudi, and Mohibullah Shah, and Nur Asyilla Che Jalil, and Suvash Chandra Ojha
January 2014, Clinical biochemistry,
Sarfraz Ahmed, and Muhammad Zeeshan Ahmed, and Safa Rafique, and Seham Eid Almasoudi, and Mohibullah Shah, and Nur Asyilla Che Jalil, and Suvash Chandra Ojha
January 2017, Indian journal of pharmacology,
Copied contents to your clipboard!